Almost exactly three years after agreeing on a $2.6 billion deal to acquire Aimmune Therapeutics and its peanut allergy therapy Palforzia, food group Nestle has sold off the business. This morning ...

Many — but not all — of the 21 drugs studied caused mutations and premature ageing in healthy blood, the researchers found.

Understand the cash flow statement for Allergy Therapeutics PLC (GB00B02LCQ05.SG), learn where the money comes from and how the company spends it.